Literature DB >> 10348824

A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote.

D F Wallace1, J S Dooley, A P Walker.   

Abstract

BACKGROUND & AIMS: Most patients with genetic hemochromatosis are homozygous for a single mutation of the HFE gene (C282Y). There is a second mutation, H63D, but its role in iron overload is less conclusive. The aim of this study was to investigate the basis of iron overload in a patient with classical hemochromatosis who was only heterozygous for C282Y and negative for H63D.
METHODS: Genotype for the C282Y, H63D, and S65C mutations of HFE was determined in patient RFH, his family members, and 365 controls. The HFE gene was sequenced in patient RFH. Allele-specific reverse-transcription polymerase chain reaction was performed to investigate RNA splicing. Allele frequency was determined by allele-specific oligonucleotide hybridization.
RESULTS: The patient is compound heterozygous for C282Y and a novel splice site mutation (IVS3 + 1G --> T). His sister has an identical genotype and elevated serum ferritin and transferrin saturation. The novel mutation functionally alters messenger RNA splicing, causing obligate skipping of exon 3. However, the IVS3 + 1G --> T mutation was found to be rare and was not detected in 630 control European chromosomes.
CONCLUSIONS: IVS3 + 1G --> T in the compound heterozygous state with C282Y results in iron overload that can progress to a severe phenotype of classical hemochromatosis. The demonstration of IVS3 +1G --> T highlights the possibility of other rare HFE mutations, particularly in C282Y heterozygotes with iron overload.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348824     DOI: 10.1016/s0016-5085(99)70505-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

Authors:  P Aguilar-Martinez; M Bismuth; M C Picot; C Thelcide; G P Pageaux; F Blanc; P Blanc; J F Schved; D Larrey
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

3.  Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Authors:  E Cadet; D Capron; M Gallet; M-L Omanga-Léké; H Boutignon; C Julier; K J H Robson; J Rochette
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

4.  Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Authors:  Patricia Aguilar-Martinez; Bernard Grandchamp; Séverine Cunat; Estelle Cadet; François Blanc; Marlène Nourrit; Kaiss Lassoued; Jean-François Schved; Jacques Rochette
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

5.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

6.  Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?

Authors:  E Ryan; V Byrnes; B Coughlan; A-M Flanagan; S Barrett; J C O'Keane; J Crowe
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 7.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

Review 9.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

Review 10.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.